Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes

SMARCB1 (INI1)-negative Rhabdoid Carcinomas of the Gastrointestinal Tract

(2014) Abbas Agaimy et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Combined Loss of E-cadherin and Aberrant β-Catenin Protein Expression Correlates With a Poor Prognosis for Small Intestinal Adenocarcinomas

(2013) Hee Jin Lee et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Right-sided rhabdoid colorectal tumors might be related to the Serrated Pathway

(2013) Massimo Pancione et al.   Diagnostic Pathology

KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas

(2013) Alyssa M Krasinskas et al.   MODERN PATHOLOGY

Rhabdoid Tumors: Clinical Approaches and Molecular Targets for Innovative Therapy

(2013) Kornelius Kerl et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions

(2012) Lisa M Sullivan et al.   MODERN PATHOLOGY

INI1-Deficient Tumors

(2011) Travis J. Hollmann et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide Repeats

(2010) Ermanno Nardon et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes

(2010) Irene Lurkin et al.   PLoS One

Giant-cell containing neoplasms of the pancreas: An aspiration cytology study

(2008) Lester J. Layfield et al.   DIAGNOSTIC CYTOPATHOLOGY